Details

Autor(en) / Beteiligte

• de Nooijer, R
• Bot, I
• von der Thüsen, J H
• Leeuwenburgh, M A
• Overkleeft, H S
• Kraaijeveld, A O
• Dorland, R
• van Santbrink, P J
• van Heiningen, S H
• Westra, M M
• Kovanen, P T
• Jukema, J W
• van der Wall, E E
• van Berkel, Th J C
• Shi, G P
• Biessen, E A L

Titel

Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis

Ist Teil von

• Arteriosclerosis, thrombosis, and vascular biology, 2009-02, Vol.29 (2), p.188

Ort / Verlag

United States

Erscheinungsjahr

2009

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• A dysbalance of proteases and their inhibitors is instrumental in remodeling of atherosclerotic plaques. One of the proteases implicated in matrix degradation is cathepsin-S (CatS). To address its role in advanced lesion composition, we generated chimeric LDLr(-/-) mice deficient in leukocyte CatS by transplantation with CatS(-/-)xLDLr(-/-) or with LDLr(-/-) bone marrow and administered a high-fat diet. No difference in aortic root lesion size could be detected between CatS(+/+) and CatS(-/-) chimeras. However, leukocyte CatS deficiency markedly changed plaque morphology and led to a dramatic reduction in necrotic core area by 77% and an abundance of large foam cells. Plaques of CatS(-/-) chimeras contained 17% more macrophages, 62% less SMCs, and 33% less intimal collagen. The latter two could be explained by a reduced number of elastic lamina fractures. Moreover, macrophage apoptosis was reduced by 60% with CatS deficiency. In vitro, CatS was found to be involved in cholesterol metabolism and in macrophage apoptosis in a collagen and fibronectin matrix. Leukocyte CatS deficiency results in considerably altered plaque morphology, with smaller necrotic cores, reduced apoptosis, and decreased SMC content and collagen deposition and may thus be critical in plaque stability.